Clinical trial
MammoVerse: Clinicians Exploring the Gaps for Treatment and Support for Women Breast Cancer Patients in Florida
NCT07644845 is registered in ClinicalTrials.gov with University of Central Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MammoVerse: Clinicians Exploring the Gaps for Treatment and Support for Women Breast Cancer Patients in Florida
- Lead sponsor
- University of Central Florida
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- February 26, 2026
- Completion date
- December 31, 2026
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer